Integration of genomics into medical practice

Discovery Medicine

Volumn 16, Issue 89, 2013, Pages 241-248

  Korf, Bruce R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; IMATINIB;

ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; CHROMOSOME ANALYSIS; CHROMOSOME DISORDER; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL (TOPIC); COPY NUMBER VARIATION; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENOMICS; HEART ARRHYTHMIA; HUMAN; MEDICAL PRACTICE; MOLECULAR DIAGNOSIS; OVARY CANCER; PHARMACOGENETICS; PHENYLKETONURIA; PRENATAL DIAGNOSIS; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

GENOME, HUMAN; HUMANS; PHARMACOGENETICS;

EID: 84889596297     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allyse M, Michie M. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Trends Biotechnol 31(8):439-441, 2013.
2. Altman RB, Kroemer HK, McCarty CA, Ratain MJ, Roden D. Pharmacogenomics: will the promise be fulfilled? Nat Rev Genet 12(1):69-73, 2011.
3. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 12(11):745-755, 2011.
4. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra64, 2011.
5. Bombard Y, Robson M, Offit K. Revealing the incidentalome when targeting the tumor genome. JAMA 310(8):795-796, 2013.
6. Calabrese G, Baldi M, Fantasia D, Teresa Sessa M, Kalantar M, Holzhauer C, Alunni-Fabbroni M, Palka G, Sitar G. Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis. Clin Genet 82(2):131-139, 2012.
7. Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 45(10):1113-1120, 2013.
8. Chiu RWK, Akolekar R, Zheng YWL, Leung TY, Sun H, Chan KCA, Lun FMF, Go ATJI, Lau ET, To WWK, Leung WC, Tang RYK, Au-Yeung SKC, Lam H, Kung YY, Zhang X, Van Vugt JMG, Minekawa R, Tang MHY, Wang J, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342:c7401, 2011.
9. Collins SC. Preimplantation genetic diagnosis: technical advances and expanding applications. Curr Opin Obstet Gynecol 25(3):201-206, 2013.
10. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, et al. A copy number variation morbidity map of developmental delay. Nat Genet, 2011.
11. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344(14):1038-1042, 2001.
12. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421-424, 2005.
13. Evans JP, Green RC. Direct to consumer genetic testing: Avoiding a culture war. Genet Med 11(8):568-569, 2009.
14. Feldman EA. The Genetic Information Nondiscrimination Act (GINA): public policy and medical practice in the age of personalized medicine. J Gen Intern Med 27(6):743-746, 2012.
15. Ferguson-Smith MA. Cytogenetics and the evolution of medical genetics. Genet Med 10(8):553-559, 2008.
16. Frueh FW, Greely HT, Green RC, Hogarth S, Siegel S. The future of direct-to-consumer clinical genetic tests. Nat Rev Genet, 2011.
17. Green R, Roberts J, Cupples L, Relkin N, Whitehouse P, Brown T, Eckert S, Butson M, Sadovnick A, Quaid K, Chen C, Cook-Deegan R, Farrer L. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 361(3):245-254, 2009.
18. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565-574, 2013.
19. Grosse SD, McBride CM, Evans JP, Khoury MJ. Personal utility and genomic information: look before you leap. Genet Med 11(8):575-576, 2009.
20. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science 339(6117):321-324, 2013.
21. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419-421, 2005.
22. Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med, 2011.
23. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385-389, 2005.
24. Kohane IS, Hsing M, Kong SW. Taxonomizing, sizing, and overcoming the incidentalome. Genet Med 14(4):399-404, 2012.
25. Korf BR, Rehm HL. New approaches to molecular diagnosis. JAMA 309(14):1511-1521, 2013.
26. Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363(19):1801-1811, 2010.
27. Levy HL, Albers S. Genetic screening of newborns. Annu Rev Genomics Hum Genet 1:139-177, 2000.
28. Lyon GJ, Jiang T, Van Wijk R, Wang W, Bodily PM, Xing J, Tian L, Robison RJ, Clement M, Lin Y, Zhang P, Liu Y, Moore B, Glessner JT, Elia J, Reimherr F, van Solinge WW, Yandell M, Hakonarson H, Wang J, et al. Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications. Discov Med 12(62):41-55, 2011.
29. Manolio TA, Collins FS, Cox NJ, Goldstein DB, HindorffLA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, et al. Finding the missing heritability of complex diseases. Nature 461(7265):747-753, 2009.
30. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749-764, 2010.
31. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, Mcdonald MT, Meisler MH, Goldstein DB. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 49(6):353-361, 2012.
32. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, Mckone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS, Vx08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365(18):1663-1672, 2011.
33. Ross LF, Saal HM, David KL, Anderson RR; American Academy of Pediatrics; American College of Medical Genetics and Genomics. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med 15(3):234-245, 2013.
34. Scott SA. Personalizing medicine with clinical pharmacogenetics. Genet Med 13(12):987-995, 2011.
35. Shearer AE, Black-Ziegelbein EA, Hildebrand MS, Eppsteiner RW, Ravi H, Joshi S, Guiffre AC, Sloan CM, Happe S, Howard SD, Novak B, Deluca AP, Taylor KR, Scheetz TE, Braun TA, Casavant TL, Kimberling WJ, Leproust EM, Smith RJ. Advancing genetic testing for deafness with genomic technology. J Med Genet 50(9):627-634, 2013.
36. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet, 2013.
37. Tabor HK, Murray JC, Gammill HS, Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Rubens CE, Santillan MK, Eichler EE, Cheng EY, Bamshad MJ, Shendure J. Non-invasive fetal genome sequencing: opportunities and challenges. Am J Med Genet A 158A(10):2382-2384, 2012.
38. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system executive summary. Pediatrics 117(Supplement 3):S296-S307, 2006.
39. Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet 13(11):795-806, 2012.